244 related articles for article (PubMed ID: 24488406)
21. Discontinuation of hypnotics during cognitive behavioural therapy for insomnia.
Zavesicka L; Brunovsky M; Matousek M; Sos P
BMC Psychiatry; 2008 Sep; 8():80. PubMed ID: 18801160
[TBL] [Abstract][Full Text] [Related]
22. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
23. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
24. Sleep pattern and predictors of daily versus as-needed hypnotics use in middle-aged and older adults with insomnia.
Tanielian M; Antoun J; Sidani M; Halabi A; Hoballah M; Hawatian K; Assaf G
BMC Prim Care; 2022 May; 23(1):98. PubMed ID: 35501700
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
26. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects.
Mathias S; Zihl J; Steiger A; Lancel M
Neuropsychopharmacology; 2005 Apr; 30(4):833-41. PubMed ID: 15602499
[TBL] [Abstract][Full Text] [Related]
27. Beliefs about prescription sleep medications and interest in reducing hypnotic use: an examination of middle-aged and older adults with insomnia disorder.
Tully IA; Kim JP; Simpson N; Palaniappan L; Tutek J; Gumport NB; Dietch JR; Manber R
J Clin Sleep Med; 2023 Jul; 19(7):1247-1257. PubMed ID: 36883379
[TBL] [Abstract][Full Text] [Related]
28. Sleep laboratory study of lormetazepam in older insomniacs.
Vogel GW
Psychopharmacology Suppl; 1984; 1():69-78. PubMed ID: 6147842
[TBL] [Abstract][Full Text] [Related]
29. Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials.
Moline M; Zammit G; Yardley J; Pinner K; Kumar D; Perdomo C; Cheng JY
Postgrad Med; 2021 Jan; 133(1):71-81. PubMed ID: 33119423
[TBL] [Abstract][Full Text] [Related]
30. Impaired driving performance associated with effect of time duration in patients with primary insomnia.
Perrier J; Bertran F; Marie S; Couque C; Bulla J; Denise P; Bocca ML
Sleep; 2014 Sep; 37(9):1565-73. PubMed ID: 25142564
[TBL] [Abstract][Full Text] [Related]
31. Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia.
Staner C; Joly F; Jacquot N; Vlasova ID; Nehlin M; Lundqvist T; Edenius C; Staner L
Curr Med Res Opin; 2010 Jun; 26(6):1423-31. PubMed ID: 20397964
[TBL] [Abstract][Full Text] [Related]
32. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
34. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood.
Roehrs T; Papineau K; Rosenthal L; Roth T
Neuropsychopharmacology; 1999 Mar; 20(3):279-86. PubMed ID: 10063488
[TBL] [Abstract][Full Text] [Related]
35. Insomnia and use of hypnotics: study of a French population.
Quera-Salva MA; Orluc A; Goldenberg F; Guilleminault C
Sleep; 1991 Oct; 14(5):386-91. PubMed ID: 1759090
[TBL] [Abstract][Full Text] [Related]
36. Zolpidem and traffic safety - the importance of treatment compliance.
Verster JC; Volkerts ER; Olivier B; Johnson W; Liddicoat L
Curr Drug Saf; 2007 Sep; 2(3):220-6. PubMed ID: 18690971
[TBL] [Abstract][Full Text] [Related]
37. [Insomnia therapy and withdrawal of hypnotics].
Garma L; Widlöcher D; Scherrer J
Sem Hop; 1982 Nov; 58(42):2441-9. PubMed ID: 6297032
[TBL] [Abstract][Full Text] [Related]
38. [Sleep disorders and hypnotic agents: medical, social and economical impact].
Touitou Y
Ann Pharm Fr; 2007 Jul; 65(4):230-8. PubMed ID: 17652991
[TBL] [Abstract][Full Text] [Related]
39. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
40. Nighttime versus daytime hypnotic self-administration.
Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
